ArticleAmerican journal of cancer research2024

Novel dual action PARP and microtubule polymerization inhibitor AMXI-5001 powerfully inhibits growth of esophageal carcinoma both alone and in combination with radiotherapy.

Nathan R Brand et al.PubMed ↗Full text ↗

No numbers read from the abstract.